Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Consumer Staples Conference on Tuesday, Sept. 5, at the InterContinental,...

Friday, August 4, 2017 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: NEW BRUNSWICK, N.J. , Aug. 4, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Barclays Global Consumer Staples Conference on Tuesday, Sept. 5 , at the InterContinental, Boston , MA. Jorge Mesquita , Executive Vice President, Worldwide Chairman, Consume

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Aug. 4, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Barclays Global Consumer Staples Conference on Tuesday, Sept. 5 , at the InterContinental, Boston , MA. Jorge Mesquita , Executive Vice President, Worldwide Chairman, Consumer will represent the Company in a session scheduled at 12:45 p.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately two hours after the live webcast.
ShareAdd on Google
Tags: JNJ Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Aug 4, 2017

Biotech snapshot

Cash runway
$20758M liquidity · $0M/mo burn
Low dilution risk
Lead asset
CanagliflozinPhase 3
Diabetes Mellitus, Type 2 →

Catalyst track record

+34%
best trade around JNJ's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for JNJ.

See every catalyst's timing & PoA →